Serina Therapeutics (SER) Q2 2025 Earnings

8MayConfirmed
Q2 2025
-0.62
-0.58
-0.53
-0.49

Details

Expected EPS
-0.62
Actual EPS
-0.49
Surprise EPS
0.13
Surprise Percent
+20.97%

Description

Serina Therapeutics (SER) has reported earnings of -0.49 per share for Q2 2025.

0 Comments

Share your thoughts